Citation: A. Sirulink et al., Marked ploidy and BCR-ABL gene amplification in vivo in a patient treated with STI571, LEUKEMIA, 15(11), 2001, pp. 1795-1797
Authors:
Cameron, CL
Cella, D
Herndon, JE
Kornblith, AB
Zuckerman, E
Henderson, E
Weiss, RB
Cooper, MR
Silver, RT
Leone, L
Canellos, GP
Peterson, BA
Holland, JC
Citation: Cl. Cameron et al., Persistent symptoms among survivors of Hodgkin's disease: An explanatory model based on classical conditioning, HEALTH PSYC, 20(1), 2001, pp. 71-75
Authors:
Michiels, JJ
Barbui, T
Finazzi, G
Fuchtman, SM
Kutti, J
Rain, JD
Silver, RT
Tefferi, A
Thiele, J
Citation: Jj. Michiels et al., Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG, LEUK LYMPH, 36(3-4), 2000, pp. 239-253
Authors:
Hensley, ML
Peterson, B
Silver, RT
Larson, RA
Schiffer, CA
Szatrowski, TP
Citation: Ml. Hensley et al., Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: Analysis of cancer and leukemia Group B 9013, J CL ONCOL, 18(6), 2000, pp. 1301-1308
Authors:
Engelhardt, M
Mackenzie, K
Drullinsky, P
Silver, RT
Moore, MAS
Citation: M. Engelhardt et al., Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture, CANCER RES, 60(3), 2000, pp. 610-617
Citation: Gw. Dewald et al., Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and theirpossible role in therapy, LEUK LYMPH, 34(5-6), 1999, pp. 481
Authors:
Michiels, JJ
Kutti, J
Stark, P
Bazzan, M
Gugliotta, L
Marchioli, R
Griesshammer, M
van Genderen, PJJ
Briere, J
Kiladjian, JJ
Barbui, T
Finazzi, G
Berlin, NI
Pearson, TC
Green, AC
Fruchtmann, SM
Silver, RT
Hansmann, E
Wehmeier, A
Lengfelder, E
Landolfi, R
Kvasnicka, HM
Hasselbalch, H
Cervantes, F
Reilly, JT
Demory, JL
Gisslinger, H
Guardiola, P
Martyre, MC
Le Bousse-Kerdiles, MC
Thiele, J
Citation: Jj. Michiels et al., Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis, NETH J MED, 54(2), 1999, pp. 46-62
Authors:
Budd, GT
Atiba, J
Silver, RT
Palmer, G
Armstrong, S
Otto, K
Presant, C
Citation: Gt. Budd et al., Phase I/II trial of human recombinant granulocyte-colony-stimulating factor (filgrastim) and escalating doses of cyclophosphamide, mitoxantrone, and 5-FU in the treatment of advanced breast cancer, J CANC RES, 125(8-9), 1999, pp. 500-504
Authors:
Silver, RT
Woolf, SH
Hehlmann, R
Appelbaum, FR
Anderson, J
Bennett, C
Goldman, JM
Guilhot, F
Kantarjian, HM
Lichtin, AE
Talpaz, M
Tura, S
Citation: Rt. Silver et al., An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology, BLOOD, 94(5), 1999, pp. 1517-1536